Cargando…

Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts

This study is to explore the molecular mechanism of benign bile duct hypertrophic scar formation. Differential proteins between the normal fibroblast (NFB) and scar fibroblast (SCFB) were screened by protein chip assay, and analyzed by pathway-enrichment analysis and function-enrichment analysis. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Shi-Kang, Tang, Jian-Zhong, Jin, Yan, Hu, Ping-Hai, Wang, Jun-Feng, Zhang, Xiao-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302586/
https://www.ncbi.nlm.nih.gov/pubmed/32541451
http://dx.doi.org/10.1097/MD.0000000000020253
_version_ 1783547877865291776
author Deng, Shi-Kang
Tang, Jian-Zhong
Jin, Yan
Hu, Ping-Hai
Wang, Jun-Feng
Zhang, Xiao-Wen
author_facet Deng, Shi-Kang
Tang, Jian-Zhong
Jin, Yan
Hu, Ping-Hai
Wang, Jun-Feng
Zhang, Xiao-Wen
author_sort Deng, Shi-Kang
collection PubMed
description This study is to explore the molecular mechanism of benign bile duct hypertrophic scar formation. Differential proteins between the normal fibroblast (NFB) and scar fibroblast (SCFB) were screened by protein chip assay, and analyzed by pathway-enrichment analysis and function-enrichment analysis. The differential proteins were further tested by ELISA. SiRNA-Act B was transfected to SCFB to down-regulate the expression of Act B. NFB was incubated with rh-Act B. The cell apoptosis and cell cycle were determined by flow cytometry. The expression of Act B, Smad2/3, transforming growth factor-β1 (TGF-β1), endothelin-1 (ET-1), thrombospondin-1 (Tsp-1), and Oncostatin M (OSM) were detected by Western blot. A total of 37 differential proteins were identified in SCFBs by microarray (P < .05), including 27 up-regulated proteins and 10 down-regulated proteins (P < .05). Their function were associated with Activin signaling, synthesis and degradation of extracellular matrix, formation and activation of cytokine, inflammatory reaction, immunoreaction, tissue damage reaction, cell cycle, migration, apoptosis, and secretion, etc. ELISA results showed that the expression of Act B, TGF-β1, ET-1 were higher in SCFBs, while the expression of Tsp-1 and OSM were lower in SCFBs (P < .05). After interfered by siRNA-Act B, the expression of Act B mRNA decreased (P < .05). The percentage of early apoptosis increased (P < .05). The expression of Act B, Smad2/3, TGF-β1 were decreased and Tsp-1, OSM were increased (P < .05). After treatment with rh-Act B, the percentage of G0/G1 phase of NFBs was decreased and that of S phase was increased without significance (P > .05). The expression of Act B, Smad2/3, TGF-β1 were increased (P < .05) and Tsp-1, OSM were decreased (P < .01). There are differentially expressed proteins between SCFBs and NFBs. Activin B signal plays an important role in the process of NFB transforming to SCFB, and TGF-β1, Smad2/3, Tsp-1, and OSM are important participants.
format Online
Article
Text
id pubmed-7302586
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73025862020-06-29 Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts Deng, Shi-Kang Tang, Jian-Zhong Jin, Yan Hu, Ping-Hai Wang, Jun-Feng Zhang, Xiao-Wen Medicine (Baltimore) 7100 This study is to explore the molecular mechanism of benign bile duct hypertrophic scar formation. Differential proteins between the normal fibroblast (NFB) and scar fibroblast (SCFB) were screened by protein chip assay, and analyzed by pathway-enrichment analysis and function-enrichment analysis. The differential proteins were further tested by ELISA. SiRNA-Act B was transfected to SCFB to down-regulate the expression of Act B. NFB was incubated with rh-Act B. The cell apoptosis and cell cycle were determined by flow cytometry. The expression of Act B, Smad2/3, transforming growth factor-β1 (TGF-β1), endothelin-1 (ET-1), thrombospondin-1 (Tsp-1), and Oncostatin M (OSM) were detected by Western blot. A total of 37 differential proteins were identified in SCFBs by microarray (P < .05), including 27 up-regulated proteins and 10 down-regulated proteins (P < .05). Their function were associated with Activin signaling, synthesis and degradation of extracellular matrix, formation and activation of cytokine, inflammatory reaction, immunoreaction, tissue damage reaction, cell cycle, migration, apoptosis, and secretion, etc. ELISA results showed that the expression of Act B, TGF-β1, ET-1 were higher in SCFBs, while the expression of Tsp-1 and OSM were lower in SCFBs (P < .05). After interfered by siRNA-Act B, the expression of Act B mRNA decreased (P < .05). The percentage of early apoptosis increased (P < .05). The expression of Act B, Smad2/3, TGF-β1 were decreased and Tsp-1, OSM were increased (P < .05). After treatment with rh-Act B, the percentage of G0/G1 phase of NFBs was decreased and that of S phase was increased without significance (P > .05). The expression of Act B, Smad2/3, TGF-β1 were increased (P < .05) and Tsp-1, OSM were decreased (P < .01). There are differentially expressed proteins between SCFBs and NFBs. Activin B signal plays an important role in the process of NFB transforming to SCFB, and TGF-β1, Smad2/3, Tsp-1, and OSM are important participants. Wolters Kluwer Health 2020-06-12 /pmc/articles/PMC7302586/ /pubmed/32541451 http://dx.doi.org/10.1097/MD.0000000000020253 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7100
Deng, Shi-Kang
Tang, Jian-Zhong
Jin, Yan
Hu, Ping-Hai
Wang, Jun-Feng
Zhang, Xiao-Wen
Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title_full Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title_fullStr Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title_full_unstemmed Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title_short Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
title_sort activin b signaling may promote the conversion of normal fibroblasts to scar fibroblasts
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302586/
https://www.ncbi.nlm.nih.gov/pubmed/32541451
http://dx.doi.org/10.1097/MD.0000000000020253
work_keys_str_mv AT dengshikang activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts
AT tangjianzhong activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts
AT jinyan activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts
AT hupinghai activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts
AT wangjunfeng activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts
AT zhangxiaowen activinbsignalingmaypromotetheconversionofnormalfibroblaststoscarfibroblasts